Document Detail


Dual time point 18F-FDG PET for the evaluation of pulmonary nodules.
MedLine Citation:
PMID:  12097455     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
18F-FDG PET has reached widespread application in the assessment of pulmonary nodules. This study compares the diagnostic accuracy of standard 18F-FDG PET scanning with those of dual time point 18F-FDG PET scanning. METHODS: Thirty-six patients (21 women, 15 men; mean age, 67 y; range, 36-88 y) with 38 known or suspected malignant pulmonary nodules underwent PET of the thorax at 2 time points: scan 1 at 70 min (range, 56-110 min) and scan 2 at 123 min (range, 100-163 min) after the intravenous injection of 2.5 MBq 18F-FDG per kilogram of body weight. All scanning was performed on a dedicated C-PET scanner. The mean interval between the scans was 56 min (range, 49-64 min). Regions of interest were overlaid onto each fully corrected image in the areas of the radiographically known lung densities. The standardized uptake values (SUVs) were calculated for both time points. RESULTS: Surgical pathology and follow-up revealed 19 patients with 20 malignant tumors, whereas 16 patients had benign lesions. The tumor SUVs (mean +/- SD) were 3.66 +/- 1.95 (scan 1) and 4.43 +/- 2.43 (scan 2) (20.5% +/- 8.1% increase; P < 0.01). Four of 20 malignant tumors had SUVs of <2.5 on scan 1 (range, 1.12-1.69). Benign lesions had SUVs of 1.14 +/- 0.64 (scan 1) and 1.11 +/- 0.70 (scan 2) (P = not significant). Standard PET scanning (single time point) with a threshold SUV of 2.5 (at time point 1) reached a sensitivity of 80% and a specificity of 94%; dual time point scanning with a threshold value of 10% increase between scan 1 and scan 2 reached a sensitivity of 100% with a specificity of 89%. CONCLUSION: Dual time point 18F-FDG PET results in a very high sensitivity and specificity for detection of malignant lung tumors.
Authors:
Alexander Matthies; Marc Hickeson; Andrew Cuchiara; Abass Alavi
Related Documents :
17229635 - A prospective comparison of 18f-fluorodeoxyglucose positron emission tomography-compute...
17384505 - Preoperative imaging staging of rectal cancer.
16777405 - The role of anatomic and functional staging in myeloma: description of durie/salmon plu...
18651155 - Tumour length measured on pet-ct predicts the most appropriate stage-dependent therapeu...
10713005 - Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluat...
15986245 - Magnetic resonance imaging in experimental chagas disease: a brief review of the utilit...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Journal of nuclear medicine : official publication, Society of Nuclear Medicine     Volume:  43     ISSN:  0161-5505     ISO Abbreviation:  J. Nucl. Med.     Publication Date:  2002 Jul 
Date Detail:
Created Date:  2002-07-04     Completed Date:  2002-07-30     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  0217410     Medline TA:  J Nucl Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  871-5     Citation Subset:  IM    
Affiliation:
Division of Nuclear Medicine, Hospital of the University of Pennsylvania, Philadelphia 19104, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenocarcinoma / radionuclide imaging
Aged
Carcinoma, Squamous Cell / radionuclide imaging
Female
Fluorodeoxyglucose F18 / diagnostic use*
Humans
Lung Neoplasms / radionuclide imaging
Male
Radiopharmaceuticals / diagnostic use
Sensitivity and Specificity
Solitary Pulmonary Nodule / radionuclide imaging*
Time Factors
Tomography, Emission-Computed / methods*
Chemical
Reg. No./Substance:
0/Radiopharmaceuticals; 63503-12-8/Fluorodeoxyglucose F18

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Regional pulmonary perfusion in patients with acute pulmonary edema.
Next Document:  Effect of respiratory gating on quantifying PET images of lung cancer.